Navigation Links
ABACHEM: Reliable Development and Manufacturing Service Provider
Date:5/9/2013

SHANGHAI, May 9, 2013 /PRNewswire/ -- ABACHEM is a public listed company in China, specializing in contract manufacturing to the pharmaceutical, biotechnological and agrochemical industries. Offering a broad spectrum of services for the production of fine chemicals, advanced intermediates and active pharmaceutical ingredients, we have successfully collaborated and partnered with major pharmaceutical and agrochemical companies globally. ABACHEM has also become a reliable development and manufacturing service provider and meets clients' outsourcing needs by offering cost-effective and time-efficient services and products.

Our R&D department has over 80 scientists with solid industrial experience, providing process research and development services including process selection, optimization, and verification as well as reference standard and impurity preparations. Our laboratory is fully-equipped with modern analytical instruments such as NMR, HPLC, UPLC, LC-MS and GC-MS to ensure that all projects are delivered with accuracy and a high degree of purity. DSC and ARSST are applied to every project in our lab to provide a process safety and hazard assessment. Our four kilo-labs ensure that all kilo-projects are delivered on time. An isolated and state-of-the-art kilo-lab was recently built and dedicated to cGMP projects.

ABACHEM promotes innovation and is open-minded to new ideas and technologies. For example, we recognize that heterocyclic chemistry and asymmetric synthesis are the two most complex and intriguing branches of organic chemistry. The development of technologies and processes for heterocyclic and asymmetric synthesis have been areas of long-term focus for the company. Heterocycles manufactured based on processes developed in-house, such as pyrazoles, triazoles, aza-indoles and unnatural amino acids, are some of the highlights. For chiral technology, besides the traditional asymmetric synthesis, we have recently enhanced our capability by establishing a biocatalysis group.

ABACHEM has tremendous manufacturing capability and capacity. Five of our multi-functional pilot plants ensure a smooth tech-transfer from lab to commercial scale manufacturing. In addition, through years of CMO business, the company has accumulated invaluable knowledge and experience in bulk hazardous material sourcing and handling as well as regulatory filing including the latest New Chemicals Substance filing. We also have had a good track record of persistent improvement of cost structure for our clients' commercial products.

ABACHEM is continuously and actively improving its capabilities and capacity through new technologies & engineering as well as expansions for our core CMO services. We have recently expanded our hydrogenation capacity significantly by the installation of an additional eighteen hydrogenation reactors ranging from 1000 to 5000 L with two 1000L Hastelloy reactors to provide excellent material compatibility.

About ABACHEM

Founded in 2003, ABACHEM has developed into a public company with about 400 employees and over 1.2 million square feet of laboratory and manufacturing space. Currently, the company is headquartered in Shanghai with a R&D center in Zhangjiang Hi-Tech Park of Shanghai and three manufacturing facilities in Jiangsu province which are all within driving distance to Shanghai. 

Contact:

Jane Wang
janewang@abachem.com
+86-136-6184-2021


'/>"/>
SOURCE ABACHEM
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Defeat Diabetes Foundation Teams with CoreMedica Laboratories to Provide Affordable and Reliable A1C Testing for Diabetics
2. Varian Medical Systems to Showcase Fast, Reliable, Wireless X-ray Image Detectors at the ECR Annual Meeting in Vienna Next Week
3. Fuisz Pharma Announces Patent Allowance For New Tablet And Caplet Shapes That Promote Rapid, Reliable Esophageal Transit
4. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
5. Trevena, Inc. and Forest Laboratories Announce a Collaborative Agreement For Development of TRV027 for the Treatment of Acute Heart Failure
6. Tribogenics Expands X-Ray Development Team With Key Hires
7. FEEL Golf Co., Inc. Signs EMR Software Development Agreement with ScheduleMorePatients LLC
8. Regeneron Acquires Full Rights to Two Novel Ophthalmology Development Programs
9. Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
10. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
11. Algeta and Lumiphore Announce Further Expansion of Their Global Partnership for the Development of Targeted Alpha-pharmaceutical Cancer Therapeutics and Companion Diagnostics.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):